On a corporate action affecting ordinary shares of Augmedix, Inc. (AUGX)

On July 19, 2024, Augmedix, Inc. signed a merger agreement with Commure, Inc. under which Commure, Inc. will acquire Augmedix, Inc. Augmedix, Inc. shareholders will to receive $2.35 in cash per share of Augmedix, Inc. that they own. The transaction is expected to close in the fourth quarter of 2024. For more details, please, refer to the company’s website.

ITS Ltd. will publish separate notices on the procedures undertaken by ITS Ltd. to process this corporate action outlining how trading in these qualified investments will be carried out.